203 related articles for article (PubMed ID: 6189445)
21. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
[TBL] [Abstract][Full Text] [Related]
22. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
23. Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung.
Davis S; Pandya MR; Rambotti P
Cancer Treat Rep; 1980; 64(4-5):685-8. PubMed ID: 6253067
[TBL] [Abstract][Full Text] [Related]
24. Combination of cis-platinum, oncovin, and bleomycin (COB) prior to surgery and/or radiotherapy in advanced untreated epidermoid cancer of the head and neck.
Peppard SB; Al-Sarraf M; Powers WE; Loh JK; Weaver AW
Laryngoscope; 1980 Aug; 90(8 Pt 1):1273-80. PubMed ID: 6157067
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
[TBL] [Abstract][Full Text] [Related]
26. Immunochemotherapy in 34 cases of oat cell carcinoma of the lung with 19 complete responses.
Israël L; Depierre A; Choffel C; Milleron B; Edelstein R
Cancer Treat Rep; 1977; 61(3):343-7. PubMed ID: 68827
[TBL] [Abstract][Full Text] [Related]
27. Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix.
Alberts DS; Martimbeau PW; Surwit EA; Oishi N
Cancer Clin Trials; 1981; 4(3):313-6. PubMed ID: 6169465
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II.
Ruckdeschel JC; Mehta CR; Salazar OM; Cohen M; Vogl S; Koons LS; Lerner H
Cancer Treat Rep; 1981; 65(11-12):965-72. PubMed ID: 7028258
[TBL] [Abstract][Full Text] [Related]
29. [Combination chemotherapy consisting of cis-platinum and adriamycin in non-small cell carcinoma of the lung].
Fujii M; Okabe K; Ishikawa M; Toki H; Fujita Y; Araki Y
Gan To Kagaku Ryoho; 1984 Feb; 11(2):265-9. PubMed ID: 6198968
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival in locally advanced oral cavity cancer: an analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery.
Ruggeri EM; Carlini P; Pollera CF; De Marco S; Ruscito P; Pinnarò P; Nardi M; Giannarelli D; Cognetti F
Head Neck; 2005 Jun; 27(6):452-8. PubMed ID: 15880411
[TBL] [Abstract][Full Text] [Related]
31. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
[TBL] [Abstract][Full Text] [Related]
32. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
Jahnke V
HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
[TBL] [Abstract][Full Text] [Related]
33. Results of a phase II protocol for evaluation of new chemotherapeutic regimens in patients with inoperable non-small cell lung carcinoma (EST-2575, generation I).
Creech RH; Mehta CR; Cohen M; Donavan M; Sponzo R; Mason BA; Skeel RT; Ahmed F; Creaven PJ; Lerner HJ; Foelsch E
Cancer Treat Rep; 1981; 65(5-6):431-8. PubMed ID: 6263476
[TBL] [Abstract][Full Text] [Related]
34. Bleomycin, vincristine, and mitomycin C with or without methotrexate in the treatment of squamous cell carcinoma.
Wheeler RH; Liepman MK; Baker SR; Earhart RH; Bull FE; Ensminger WD
Cancer Treat Rep; 1980; 64(8-9):943-9. PubMed ID: 6160914
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
[TBL] [Abstract][Full Text] [Related]
37. Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.
Young JA; Dillman RO; Seagren SL; Taetle R; Rentschler RE; Lea JW; Lehar TJ; Green MR; Stanton W; Mendelsohn J; Royston I
Cancer Treat Rep; 1982 Jun; 66(6):1399-401. PubMed ID: 6282459
[TBL] [Abstract][Full Text] [Related]
38. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
[TBL] [Abstract][Full Text] [Related]
39. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized study.
Richman SP; Livingston RB; Gutterman JU; Suen JY; Hersh EM
Cancer Treat Rep; 1976 May; 60(5):535-9. PubMed ID: 62613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
